Why the study?
Late recurrence of atrial fibrillation within the first year after catheter ablation is a common and significant clinical problem, prompting the need for predictive models.
Can machine learning models predict late recurrence of atrial fibrillation within the first year after catheter ablation in patients with AF?
Can machine learning models predict late recurrence of atrial fibrillation within the first year after catheter ablation in patients with AF?
An XGBoost machine learning model using 12 clinical and laboratory variables can predict late recurrence of atrial fibrillation within 1 year after catheter ablation with good performance (AUC 0.75).
May support post-ablation AF risk stratification; leaves open clinical utility pending prospective validation.
Late recurrence of atrial fibrillation (LRAF) in the first year following catheter ablation is a common and significant clinical problem. Our study aimed to create a machine-learning model for predicting arrhythmic recurrence within the first year since catheter ablation. The study comprised 201 consecutive patients (age: 61.8 ± 8.1; women 36%) with paroxysmal, persistent, and long-standing persistent atrial fibrillation (AF) who underwent cryoballoon (61%) and radiofrequency ablation (39%). Five different supervised machine-learning models (decision tree, logistic regression, random forest, XGBoost, support vector machines) were developed for predicting AF recurrence. Further, SHapley Additive exPlanations were derived to explain the predictions using 82 parameters based on clinical, laboratory, and procedural variables collected from each patient. The models were trained and validated using a stratified fivefold cross-validation, and a feature selection was performed with permutation importance. The XGBoost model with 12 variables showed the best performance on the testing cohort, with the highest AUC of 0.75 [95% confidence interval 0.7395, 0.7653]. The machine-learned model, based on the easily available 12 clinical and laboratory variables, predicted LRAF with good performance, which may provide a valuable tool in clinical practice for better patient selection and personalized AF strategy following the procedure.
No takes yet. Share an insight, caveat, or question.
Budzianowski et al. (2023) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: